•  
  •  
  •  
  •  

2026-07-12 20:54:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • LTM Limited Commences FY27 with Robust Trajectory as Q1 Net Profit Climbs 17% Year-on-Year to ₹14,686 Million
  • Gowra Leasing & Finance Q1 FY27 Net Profit Surges 123% Year-on-Year to ₹288.32 Lakh
  • Avenue Supermarts Unveils Q1 FY27 Performance: Net Profit Climbs to ₹860.44 Crore Amid Strong Operational Scaling
  • Avantel Limited Net Profit Climbs 67% Year-on-Year to ₹539.46 Lakh in Q1 FY27; Sequentially Up 13%
  • Just Dial Net Profit Climbs 4.1% Year-on-Year to ₹1,662.2 Million; Sequentially Surges 66%

Keywords Selected:  Approval

IPO News

  • SEBI Clears IPO for EAAA India Alternatives Ltd, Edelweiss Subsidiary to Launch ₹15,000 Million OFS
  • VMS TMT Limited Gets SEBI Nod to Float an IPO
  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • Icon Facilitators Announces BSE SME IPO Approval, Targets ₹22 Crore Fundraise
  • Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
  • Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO
  • Senores Pharmaceuticals gets Sebi nod for IPO
  • Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO
  • IT Solutions provider Orient Technologies gets Sebi nod for IPO
  • Gala Precision Engineering gets Sebi nod for IPO
  • Noida-based Interarch Building Products Limited gets SEBI nod for IPO
  • Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO
  • Allied Blenders and Distillers Limited gets Sebi nod for Rs 1500 crore IPO
  • Sanstar Limited, gets SEBI nod to float IPO
  • Asirvad Micro Finance Limited gets Sebi nod for IPO
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Fairfax-backed Go Digit General Insurance gets Sebi nod for IPO
  • Gopal Snacks Limited gets Sebi nod for Rs 650 crore IPO
  • Juniper Hotels gets Sebi nod for its Rs 1,800 crore IPO
  • Stanley Lifestyles gets Sebi nod for IPO
  • Onest and Shiva Pharmachem gets Sebi nod for IPO
  • Mukka Proteins Limited gets Sebi Nod for IPO
  • Ludhiana-based Auto Component Maker Happy Forgings Limited receives Sebi nod to float its IPO
  • Cello World Limited gets Sebi nod for its Rs 1750 crore IPO

Stock Report

  • NTPC board approves investment in Lara Super Thermal Power Project
  • Cosmic CRF Subsidiary's Target Unit Secures RDSO Prototype Approval for Railway Springs
  • NATCO Pharma Ltd gets approval from its Board of Directors for increasing its stake in Adcock Ingram Holdings Proprietary Ltd to 49%
  • Lupin announces EMA Approval for NaMuscla® Expansion for Pediatric Indication with New Strengths
  • EPACK Durable Ltd receives Andhra Pradesh Government approval for ₹1,084.31 Crore combined investment under Electronics Manufacturing Policy 4.0
  • Approval of Merger scheme by Board of Directors of PFC and REC
  • Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapsone Gel, 5%
  • Lupin receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
  • Accord Transformer & Switchgear Ltd receives Vendor Registration Approval from UGVCL
  • Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
  • TruAlt Bioenergy secures ₹150 crore financial assistance approval under PM JI-VAN Yojana for Sustainable Aviation Fuel Project
  • AU Small Finance Bank and Motilal Oswal Financial Services announced Enhanced 3-in-1 Account Experience
  • Steel Exchange India Secures APCRDA Approval for SIMHADRI TMT in Amaravati Capital City Projects
  • Lancor Holdings Ltd receives RERA approval for Lancor Ananya
  • Alembic Pharmaceuticals Ltd announces USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg
  • Neetu Yoshi Ltd receives approval from RCF, Kapurthala
  • Concord Biotech Ltd receives ANDA approval for Tofacitinib Tablets, 5 mg and 10 mg
  • KD Green Industries announces proposed merger with KD Iron & Steel
  • Wanbury Ltd submits APIs for regulatory approvals
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg
  • Lupin receives approval from U.S. FDA for Ranluspec™ (ranibizumab) Injection
  • Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
  • Akums Receives European CEP Approval for Cefpodoxime Proxetil
  • NATCO and Lupin receive approval from U.S. FDA for Eribulin Mesylate Injection

Industry News

  • ASK Asset & Wealth Management Group receives SEBI nod to launch its Mutual Fund business
  • Ashika Investment Managers Launches SmartAlpha Fund, a New Open-Ended Category III Data Strategy Fund
  • RBI grants NBFC license to Equirus Group
  • NCLT approves slice and North East Small Finance Bank's Merger
  • NSE launches WTI Crude Oil and Natural Gas futures contracts
  • Zero To One, an angel network, gets SEBI nod to launch INR 300cr Alternative Investment Fund
  • Pre Construction Tips: Things to Check
  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license
  • Insurance product approvals made easy - Steps towards ease of doing business

Latest Post

  • LTM Limited Commences FY27 with Robust Trajectory as Q1 Net Profit Climbs 17% Year-on-Year to ₹14,686 Million
  • Gowra Leasing & Finance Q1 FY27 Net Profit Surges 123% Year-on-Year to ₹288.32 Lakh
  • Avenue Supermarts Unveils Q1 FY27 Performance: Net Profit Climbs to ₹860.44 Crore Amid Strong Operational Scaling
  • Avantel Limited Net Profit Climbs 67% Year-on-Year to ₹539.46 Lakh in Q1 FY27; Sequentially Up 13%
  • Just Dial Net Profit Climbs 4.1% Year-on-Year to ₹1,662.2 Million; Sequentially Surges 66%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025